Education
About Us
Working with TipRanks
Follow Us
Alligator Bioscience AB (SE:ATORX)
:ATORX
ATORX Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr4.30 - kr225.00
Previous CloseN/A
Volume998.30M
Average Volume (3M)199.02K
Market Cap
kr79.17M
Enterprise Valuekr168.03M
Total Cash (Recent Filing)kr28.85M
Total Debt (Recent Filing)kr41.86M
Price to Earnings (P/E)―
Beta1.23
Next Earnings
Jul 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-27.27
Shares Outstanding16,905,478
10 Day Avg. Volume103,985
30 Day Avg. Volume199,023
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
ATORX FAQ
What was Alligator Bioscience AB’s price range in the past 12 months?
Alligator Bioscience AB lowest stock price was kr4.30 and its highest was kr225.00 in the past 12 months.
What is Alligator Bioscience AB’s market cap?
Alligator Bioscience AB’s market cap is kr79.17M.
When is Alligator Bioscience AB’s upcoming earnings report date?
Alligator Bioscience AB’s upcoming earnings report date is Jul 10, 2025 which is in 74 days.
How were Alligator Bioscience AB’s earnings last quarter?
Currently, no data Available
Is Alligator Bioscience AB overvalued?
According to Wall Street analysts Alligator Bioscience AB’s price is currently Overvalued.
Does Alligator Bioscience AB pay dividends?
Alligator Bioscience AB does not currently pay dividends.
What is Alligator Bioscience AB’s EPS estimate?
Alligator Bioscience AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alligator Bioscience AB have?
Alligator Bioscience AB has 16,905,478 shares outstanding.
What happened to Alligator Bioscience AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Alligator Bioscience AB?
Currently, no hedge funds are holding shares in SE:ATORX
---
Company Description
Alligator Bioscience AB
Alligator Bioscience AB is a biotech company, which engages in the development of innovative antibody- based medicines for immunotherapy of cancer. It specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company was founded by Carl Arne Krister Borrebaeck in 2001 and is headquartered in Lund, Sweden.
---
Technical Analysis
Biosergen AB
―
Xintela AB
―
Elicera Therapeutics AB
―
ExpreS2ion Biotech Holding AB
―
Active Biotech AB
―
---